Correlation Between Hard To and Lifeline Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Hard To and Lifeline Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hard To and Lifeline Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hard to Treat and Lifeline Biotechnologies, you can compare the effects of market volatilities on Hard To and Lifeline Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hard To with a short position of Lifeline Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hard To and Lifeline Biotechnologies.
Diversification Opportunities for Hard To and Lifeline Biotechnologies
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hard and Lifeline is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hard to Treat and Lifeline Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lifeline Biotechnologies and Hard To is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hard to Treat are associated (or correlated) with Lifeline Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lifeline Biotechnologies has no effect on the direction of Hard To i.e., Hard To and Lifeline Biotechnologies go up and down completely randomly.
Pair Corralation between Hard To and Lifeline Biotechnologies
If you would invest 0.03 in Lifeline Biotechnologies on September 23, 2024 and sell it today you would lose (0.02) from holding Lifeline Biotechnologies or give up 66.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 76.61% |
Values | Daily Returns |
Hard to Treat vs. Lifeline Biotechnologies
Performance |
Timeline |
Hard to Treat |
Lifeline Biotechnologies |
Hard To and Lifeline Biotechnologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hard To and Lifeline Biotechnologies
The main advantage of trading using opposite Hard To and Lifeline Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hard To position performs unexpectedly, Lifeline Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will offset losses from the drop in Lifeline Biotechnologies' long position.Hard To vs. Fate Therapeutics | Hard To vs. Sana Biotechnology | Hard To vs. Caribou Biosciences | Hard To vs. Arcus Biosciences |
Lifeline Biotechnologies vs. Armm Inc | Lifeline Biotechnologies vs. Cellink AB | Lifeline Biotechnologies vs. Bone Biologics Corp | Lifeline Biotechnologies vs. BICO Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |